Atea Pharmaceuticals, Inc. Common Stock

AVIR XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

340M

Short interest (May 15)

9.5%

Borrow Fee

0.42%

↓ 7.5%

Available Shares

800K

↓ 8.7%

Price Chart

Company Overview

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001593899

Asset Type: CS

Market Data

Market Cap: $341,715,712

Employees: 55

Status: Active

Short Interest

Current Borrow Fee 0.42%

Range: 0.40% - 0.48%

Available Shares 800K

Range: 650K - 800K

Recent Changes

Fee Change: ↓ 2.6%

Available Change: ↓ 2.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime